Marking the tumor with a clip pre-treatment and preoperative MRI are recommended for patients receiving neoadjuvant chemotherapy to evaluate the response to chemotherapy and guide surgery, especially in the case of Her2-positive tumors, where the risk of scattered response is higher. The gene discussed is ERBB2; the disease is neoplasm.